# THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL

> **NIH NIH N01** · IRISYS, INC. · 2024 · $180,000

## Abstract

Dosage Form Development, Manufacture and Stability Studies of ORC-13661 for Phase II Clinical
Trial

## Key facts

- **NIH application ID:** 11221085
- **Project number:** 271201700020I-P00001-759502200001-1
- **Recipient organization:** IRISYS, INC.
- **Principal Investigator:** TIM BOURQUE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $180,000
- **Award type:** —
- **Project period:** 2022-09-28 → 2027-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11221085

## Citation

> US National Institutes of Health, RePORTER application 11221085, THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL (271201700020I-P00001-759502200001-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11221085. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*